High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal Cancer
NCT03007836
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Nasopharyngeal Cancer
Interventions
BIOLOGICAL:
High-activity natural killer
Sponsor
Fuda Cancer Hospital, Guangzhou
Collaborators
[object Object]